Products

Acetadote^®

This product prevents or reduces liver damage resulting from acetaminophen overdose, the leading cause of drug toxicity in the U.S. Promoted to hospitals and poison control centers nationwide, Acetadote is the first injectable treatment available in the country for this potentially lethal overdosing occurrence.

Kristalose^®

Kristalose is a prescription laxative that we believe has significant advantages over competitive products, and is being promoted to the most prolific prescribers of the class - gastroenterologists.

Pipeline

Phase III Development

Amelior^®

Amelior is our intravenous formulation of ibuprofen which is currently in Phase III clinical trials. We are preparing to submit our NDA for the product to the FDA in the second half of 2008. If approved by the FDA, we expect Amelior to be the first injectable product available in the United States for the treatment of pain and fever.